Aptevo Therapeutics Inc. — Director's Dealing 2025

Jul 21, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aptevo Therapeutics Inc. (APVO)
CIK: 0001671584
Period of Report: 2025-07-17

Reporting Person: Kunz Barbara Lopez (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-07-17	Common Stock	M	1	—	Acquired	1	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-07-17	Restricted Stock Unit	$	M	1	Disposed		Common Stock (1)	Direct

Footnotes

F1: Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.

F2: On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant.